UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 12, 2020

Accession Number:	0001178913-20-002305
Submission Type:	POS AM
CIK: 0001498403 Company Name: BioLineRx Ltd. File Number: 333-239485